DNDi Template Development Collaboration and License Agreement Post author:GHIAA Admin Post published:April 19, 2023 Post category: Continue ReadingDNDi Template Development Collaboration and License Agreement
National Health Service (NHS) – Pfizer/Shionogi, Antibiotic Supply Agreement Post author:GHIAA Admin Post published:March 2, 2023 Post category: Continue ReadingNational Health Service (NHS) – Pfizer/Shionogi, Antibiotic Supply Agreement
CEPI – VBI, COVID-19 Vaccine Development Funding Agreement Post author:GHIAA Admin Post published:December 12, 2022 Post category: Continue ReadingCEPI – VBI, COVID-19 Vaccine Development Funding Agreement
DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement Post author:GHIAA Admin Post published:October 27, 2022 Post category: Continue ReadingDNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement Post author:GHIAA Admin Post published:September 14, 2022 Post category: Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement
CEPI – Novavax, COVID-19 Vaccine Funding Agreement Post author:GHIAA Admin Post published:August 25, 2022 Post category: Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement
Gates Foundation – Icosavax, COVID-19 Vaccine Global Access and Price Commitments Agreement Post author:GHIAA Admin Post published:August 11, 2022 Post category: Continue ReadingGates Foundation – Icosavax, COVID-19 Vaccine Global Access and Price Commitments Agreement
Shionogi – GARDP, Cefiderocol License Agreement Post author:GHIAA Admin Post published:July 8, 2022 Post category: Continue ReadingShionogi – GARDP, Cefiderocol License Agreement
NIH – MPP, COVID-19 Patent and Biological Material License Agreement Post author:GHIAA Admin Post published:June 29, 2022 Post category: Continue ReadingNIH – MPP, COVID-19 Patent and Biological Material License Agreement